MedTrace Logo

The Verona Newly Diagnosed Type 2 Diabetes Study

NCT01526720 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2012-02-06

No results posted yet for this study

Summary

Type 2 diabetes mellitus is a complex disease whose clinical phenotype results from the variable combination of genetic and nongenetic factors. The aim of the present study is to investigate the network linking phenotypes and genotypes in patients with newly diagnosed type 2 diabetes mellitus. In selected cases, in which clinical evidence hints at possible monogenic basis of the disease, the genotype and the phenotype of relatives also will be assessed to elucidate further the etiology of the disease.

Conditions

Sponsors & Collaborators

  • European Foundation for the Study of Diabetes

    collaborator OTHER

  • Ministry of Education, Universities and Research, Italy

    collaborator OTHER

  • Universita di Verona

    lead OTHER

Principal Investigators

  • Enzo Bonora, MD PhD · Section of Endocrinology, Diabetes and Metabolism - Department of Medicine, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy

  • Riccardo C Bonadonna, MD · Section of Endocrinology, Diabetes and Metabolism - Department of Medicine, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-10-31
Primary Completion
2019-12-31
Completion
2020-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01526720 on ClinicalTrials.gov